# Pennington Biomedical Research Center study finds that THC and CBD combats dementia … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/pennington-biomedical-research-center-study-finds-that-thc-and-cbd-combats-dementia/ > **Published:** 2026-07-30T12:22:53-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:58:16-04:00 > **Clinical Summary:** Pennington dementia trial examining THC and CBD shows early findings. Here's what the evidence actually supports for clinical practice. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyTHCCBDAgingSafety[Mental Health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) Clinical Summary # Clinical Summary A study from Pennington Biomedical Research Center examined the effects of THC and CBD combinations in dementia models, with findings suggesting potential therapeutic benefit for [cognitive decline](https://cedclinic.com/cannabis-cognitive-safety-in-older-adults/). The research indicates that the cannabinoid combination may work through neuroprotective mechanisms relevant to dementia pathophysiology, though the available summary lacks specific details on study design, patient population, and primary outcomes needed for full clinical evaluation. These preliminary findings could inform future [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) in dementia patients, though clinicians should note that evidence remains limited and regulatory pathways for cannabis-based dementia treatments remain unclear in most jurisdictions. Given the growing interest in [cannabinoid-based therapeutics](https://cedclinic.com/cannabis-use-disorder-treatment-pipeline-gains-momentum/) and the current lack of disease-modifying options for many dementia types, this research direction warrants attention but requires validation through rigorous randomized controlled trials in human subjects. Clinicians considering cannabis discussion with dementia patients should await more robust clinical evidence before recommending cannabinoid treatments, while remaining aware of ongoing research in this area. Clinical Perspective ⚠️ While preliminary findings from animal and in vitro models suggesting neuroprotective effects of THC and CBD combinations warrant attention, clinicians should exercise considerable caution before incorporating cannabis into dementia management. The translation from basic research to meaningful clinical benefit remains uncertain, and several critical questions persist: the optimal dosing and cannabinoid ratios, long-term safety profiles in elderly populations with multiple comorbidities, potential drug interactions with common dementia medications, and whether effects observed in controlled laboratory settings replicate in human [cognitive decline](https://cedclinic.com/cannabis-cognitive-safety-in-older-adults/). Additionally, cognitive and psychiatric [side effects](https://cedclinic.com/cannabis-intoxication-memory-disruption/) of THC—particularly in older adults—may actually worsen dementia symptoms rather than improve them, and regulatory barriers continue to limit rigorous human trials in North America. Until well-designed randomized controlled trials in human subjects demonstrate clinically significant benefit with acceptable safety profiles, cannabis cannot be recommended as a standard dementia therapy, though discussing emerging research may be appropriate when patients or families inqu 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Pennington%20Biomedical%20Research%20Center%20study%20finds%20that%20THC%20and%20CBD%20combats%20dementia%20...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D71769)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D71769)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Pennington%20Biomedical%20Research%20Center%20study%20finds%20that%20THC%20and%20CBD%20combats%20dementia%20...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D71769)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://louisianaradionetwork.com/2026/07/30/47583/](https://louisianaradionetwork.com/2026/07/30/47583/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).